Back
Genuine Parts 10K Form
Sell
40
GPC
Genuine Parts
Last Price:
124.80
Seasonality Move:
3.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-18 | 10Q | GPC/Genuine Parts Quarterly |
| 2024-02-22 | 10K | GPC/Genuine Parts Annual |
| 2023-10-19 | 10Q | GPC/Genuine Parts Quarterly |
| 2023-07-20 | 10Q | GPC/Genuine Parts Quarterly |
| 2023-04-20 | 10Q | GPC/Genuine Parts Quarterly |
| 2023-02-23 | 10K | GPC/Genuine Parts Annual |
Receive GPC News And Ratings
See the #1 stock for the next 7 days that we like better than GPC
GPC Financial Statistics
Sales & Book Value
| Annual Sales: | $23.09B |
|---|---|
| Cash Flow: | $357.97M |
| Price / Cash Flow: | 19.39 |
| Annual Sales: | $33.77 |
| Price / Book: | 3.69 |
Profitability
| EPS (TTM): | 7.77000 |
|---|---|
| Net Income (TTM): | $1.09B |
| Gross Margin: | $8.29B |
| Return on Equity: | 24.39% |
| Return on Assets: | 5.88% |
Genuine Parts Earnings Forecast
Key Genuine Parts Financial Ratios
- The Gross Profit Margin over the past 40 years for GPC is 35.90%.
- The Selling, General & Administrative Expenses for GPC have been equal to 26.71% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 4.90% of Operating Income.
- The Net Earning history of GPC is 5.70% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 30 years.
Genuine Parts Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Distributors |
| Sector: | Consumer Discretionary |
| Current Symbol: | GPC |
| CUSIP: | 372460 |
| Website: | genpt.com |
Debt
| Debt-to-Equity Ratio: | 0.98 |
|---|---|
| Current Ratio: | 1.17 |
| Quick Ratio: | 0.49 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.38 |
|---|---|
| Forward P/E Ratio: | 14.51 |
GPC Technical Analysis vs Fundamental Analysis
Sell
40
Genuine Parts (GPC)
is a Sell
Is Genuine Parts a Buy or a Sell?
-
Genuine Parts stock is rated a Sell
The current Genuine Parts [GPC] share price is $124.80. The Score for GPC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.